New-onset atrial fibrillation detected by ambulatory ECG monitoring after transcatheter aortic valve implantation.

ABSTRACT:

Background

Little is known about the occurrence of subclinical new-onset atrial fibrillation (NOAF) after transcatheter aortic valve implantation (TAVI).

Aims

We aimed to evaluate the incidence, predictors, and clinical impact of subclinical NOAF after TAVI.

Methods

This was a multicentre study, including patients with aortic stenosis (AS) and no previous atrial fibrillation undergoing TAVI, with continuous ambulatory electrocardiogram (AECG) monitoring after TAVI.

Results

A total of 700 patients (79±8 years, 49% female, Society of Thoracic Surgeons score 2.9% [1.9-4.0]) undergoing transarterial TAVI were included (85% balloon-expandable valves). AECG was started 1 (0-1) day after TAVI (monitoring time: 14

SUBMITTER: Nuche J 

PROVIDER: S-EPMC11067725 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature